Previous close | 43.54 |
Open | 0.00 |
Bid | 40.34 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 155,825 |
Market cap | 9.463B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 28.47 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week.
QIAGEN (QGEN) supports the new TB screening guidelines from AAP, recommending IGRA tests like QFT-Plus to screen at-risk children of all ages.
QIAGEN's (QGEN) latest QCI Interpret release improves the performance of high-throughput NGS labs.